UCB SA UNSP/ADR by UCB S.A. (UCBJY) Stock Price, Quote, News & History

Key Statistics

Open

$128.49

Volume / Avg.

0 / 37.55K

Day Range

- - -

52 Wk Range

114.53 - 168.76

Market Cap

P/E Ratio

19.46

Dividend Yield

0.66%

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Ucb SA News

UCB Data Reinforce Long-Term Promise For Weak Muscles Disorder

UCB presents data showing rozanolixizumab & zilucoplan deliver sustained symptom relief for generalized myasthenia gravis (gMG).

Vandana Singh

Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle

CMS selects 15 high-cost prescription drugs for Medicare drug price negotiation program, expanding to include Part B drugs.

Vandana Singh

Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment

Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE.

Vandana Singh

J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline

Johnson & Johnson ends its Phase 2b posdinemab trial after missing key Alzheimer's goals, raising concerns for next-generation tau-targeting drug programs.

Vandana Singh

RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program

Eli Lilly and Amgen are suing HHS over 340B certifications, claiming ineligible clinics cost them millions in lost revenue.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.95B

Investing Cash Flow (TTM)

-2.91B

Financing Cash Flow (TTM)

98.00M

Free Cash Flow (TTM)

1.29B

Capital Expenditure (TTM)

-664.00M

Net Change in Cash (TTM)

-859.00M

Valuation Metrics

Enterprise Value

$51.99B

PE Ratio (TTM)

19.46

PE Ratio (FWD)

18.55

PEG Ratio (TTM)

1.33

PS Ratio (TTM)

5.01

PB Ratio (TTM)

3.60

Earnings Yield % (TTM)

5.14%

Earnings Yield % (FWD)

5.39%

EV / EBITDA (TTM)

13.69

Price / EBITDA (TTM)

13.12

Price / Free Cash Flow (TTM)

33.22

Book Value / Share

$35.66

Company Debt

Total Debt

$3.38B

LT Debt

$3.23B

LT Debt Issuance (TTM)

$1.44B

LT Debt Repayment (TTM)

-$775.00M

Total Cash

$766.00M

Debt to Equity

0.31

Issuance of Debt (TTM)

$668.00M

Repayment of Debt (TTM)

-$775.00M

Key Statistics

Open

$128.49

Volume / Avg.

0 / 37.55K

Day Range

- - -

52 Wk Range

114.53 - 168.76

Market Cap

P/E Ratio

19.46

Dividend Yield

0.66%

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which h...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

UCBJY

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

UCBJY

FAQ

How do I buy UCB SA UNSP/ADR by UCB S.A. (UCBJY) stock?

You can purchase shares of UCB SA UNSP/ADR by UCB S.A. (OTCPK:UCBJY) through any online brokerage.

View our list of the best stock brokerages

Who are UCB SA UNSP/ADR by UCB S.A. (UCBJY) competitors?

There are no as such competitors for UCB SA UNSP/ADR by UCB S.A..

What is the forecast, or price target, for UCB SA UNSP/ADR by UCB S.A. (UCBJY) stock?

There is no analysis for UCB SA UNSP/ADR by UCB S.A. to provide a consensus price target.

What is the current price for UCB SA UNSP/ADR by UCB S.A. (UCBJY)?

The stock price for UCB SA UNSP/ADR by UCB S.A. (OTCPK: UCBJY) is $128.49 last updated August 26, 2026 at 3:59 PM EDT.

Does UCB SA UNSP/ADR by UCB S.A. (UCBJY) pay a dividend?

There are no upcoming dividends for UCB SA UNSP/ADR by UCB S.A..

When is UCB SA UNSP/ADR by UCB S.A. (OTCPK:UCBJY) reporting earnings?

UCB SA UNSP/ADR by UCB S.A. does not have any upcoming earnings scheduled.

Is UCB SA UNSP/ADR by UCB S.A. (UCBJY) going to split?

There is no upcoming split for UCB SA UNSP/ADR by UCB S.A..

What sector and industry does UCB SA UNSP/ADR by UCB S.A. (UCBJY) operate in?

UCB SA UNSP/ADR by UCB S.A. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.